v3.25.2
Document And Entity Information - shares
 6 Months Ended
Jun. 30, 2025
Jul. 31, 2025
Document Information [Line Items]    
Entity Central Index Key 0001855175  
Entity Registrant Name Contineum Therapeutics, Inc.  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2025  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2025  
Document Transition Report false  
Entity File Number 001-42001  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 27-1467257  
Entity Address, Address Line One 3565 General Atomics Court, Suite 200  
Entity Address, City or Town San Diego  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92121  
City Area Code 858  
Local Phone Number 333-5280  
Title of 12(b) Security Class A Common Stock, $0.001 par value per share  
Trading Symbol CTNM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   28,041,895